Prebiotic pill aimed to tame morning stress hormone – but trial never started

NCT ID NCT06566157

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study planned to test whether taking a prebiotic supplement for six weeks could reduce morning cortisol levels in healthy young adults aged 18-25 with mild to moderate stress. Participants would have provided saliva, stool, urine, and blood samples. However, the trial was withdrawn before any volunteers were enrolled, so no results are available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Prebiotic supplement (WellBiome® - inulin, XOS, magnesium chloride)
What this could lead to
If it had worked, this could point toward a simple dietary supplement to help manage stress and improve wellbeing in young adults.
What could go wrong
The trial was withdrawn before enrolling anyone, so no data was collected. Even if run, the effect on cortisol is uncertain and may not translate to real-world stress relief.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Psychological Well-Being

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • NIHR Southampton Clinical Research Facility

    Southampton, Hampshire, SO16 6YD, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.